Magnetic Nanoparticles Enhance Movement in Parkinsonian Mice

In a novel approach to addressing movement disorders, researchers injected magnetic nanoplatelets into specific brain regions of mice exhibiting Parkinson’s-like symptoms and applied a magnetic field to improve their motor functions.

This method offers a less invasive alternative to traditional deep brain stimulation, which typically requires surgically implanted electrodes. The study was conducted by scientists from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), RWTH Aachen, Maastricht University, and KU Leuven, with findings published in Advanced Science.

How Magnetic Nanoparticles Influence Brain Circuits

Parkinson’s disease leads to the gradual loss of dopamine-producing brain cells, disrupting motor circuits and causing symptoms such as tremors. Conventional treatment involves implanting a brain pacemaker beneath the collarbone to send electrical signals to the subthalamic nucleus (STN), a deep brain area critical for movement control.

Professor Danijela Gregurec from FAU’s Department of Chemistry and Pharmacy explained that the magnetic nanoparticles implanted in the brain are designed to convert magnetic fields into minute mechanical forces. Unlike electrical stimulation, this technique leverages neurons’ natural mechanosensors to modulate activity.

When exposed to a magnetic field, the particles generate small mechanical forces that deform nearby cell membranes, activating mechanosensitive channels and allowing ions to enter nerve cells, thereby influencing neural activity.

Testing and Results in Parkinsonian Mouse Models

The research team injected magnetic nanoparticles into the subthalamic nucleus of mice with nerve cell damage similar to that seen in Parkinson’s disease. Precise placement was achieved through stereotactic procedures to target the correct motor circuit.

Following exposure to the magnetic field, the mice showed significant improvement in movement deficits, with effects comparable to those expected from brain pacemaker implantation, according to Gregurec.

Safety and Future Directions

The nanoparticles remained in the animals’ brains for several months without signs of inflammation, indicating good tolerance during the study period. The team is now investigating non-invasive delivery methods, such as intravenous administration designed to cross the blood-brain barrier.

Additionally, efforts are underway to develop compact wearable devices capable of generating the required magnetic fields. One proposed design is a headband that patients could easily place themselves, although clinical application remains several years away.

Gregurec emphasized the potential benefits of this method, noting its simplicity, cost-effectiveness, and flexibility compared to conventional brain pacemakers. Adjusting magnetic field parameters could allow more precise control of the nanoparticles.

Beyond therapeutic use, the technique may also provide a valuable research tool for studying how mechanical forces influence brain function.